- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03703739
Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents
Effect of Solubilizing Agents on Iron Absorption From Iron Fortified Rice in Young Women
Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Ferric pyrophosphate (FePP) is an acceptable iron compound for rice fortification, due to its white colour and low reactivity with the rice matrix. However, iron from FePP generally has a low bioavailability. To increase the low iron bioavailability of FePP in fortified rice, ligands acting as solubilizing agents have been suggested, such as citric acid/trisodium citrate (CA/TSC), ethylenediaminetetraacetic acid (EDTA) and sodium pyrophosphate (NaPP).
It is however unclear to which extent CA/TSC would enhance iron bioavailability in presence of phytic acid, a common inhibitor of iron absorption found in whole grains and legumes. Zinc oxide reduces iron bioavailability from FePP with and without CA/TSC, in contrast to Zinc sulphate. It is however unclear if this decrease would be also expected in presence of EDTA as solubilizing agent. Further, NaPP has been suggested as a solubilizing agent, enhancing the bioavailability from FePP in bouillon cubes. This study aim to test its effect in rice. Meals containing a high (bean sauce) and low (mixed vegetable) phytic acid level sauce will be used to simulated varying dietary backgrounds, allowing to answer the question which solubilizing agent is viable in enhancing iron bioavailability.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8092
- Human Nutrition Laboratory, ETH Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female, 18 to 40 years old
- Normal body Mass Index (18.5 - 25 kg/m2)
- Body weight ≤ 65 kg
- Signed informed consent
Exclusion Criteria:
- Pregnancy (assessed by self-declaration)
- Lactating up to 6 weeks before study initiation
- Anaemia (Hb < 12.0 g/dL)
- Elevate CRP (>5.0 mg/L)
- Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement)
- Continuous/long-term use of medication during the whole study (except for contraceptives)
- Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration
- Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months
- Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days
- Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments)
- Smokers (> 1 cigarette per week)
- Difficulties with blood sampling
- Male gender
- Do not understand English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Reference meal 1
50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants.
Rice meal consumed with mixed vegetable Sauce.
|
1 ml Ferrous sulfate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant.
The meal served with 30 g mixed vegetable Sauce and 300 ml nanopure water
|
Active Comparator: Reference 2
50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants.
Rice meal consumed with bean sauce.
|
1 ml Ferrous sulphate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant.
The meal served with 30 g bean Sauce and 300 ml nanopure water
|
Experimental: Test meal A
Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice cofortified with zinc oxide and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
|
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc oxide and ethylenediaminetetraacetic acid |
Experimental: Test meal B
Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
|
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and ethylenediaminetetraacetic acid |
Experimental: Test meal C
Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
|
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate. |
Experimental: Test meal D
Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfafe and sodium pyrophosphate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
|
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and sodium pyrophosphate. |
Experimental: Test meal E
Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with bean Sauce.
|
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g bean Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in the isotopic ratio of iron in blood at week 2
Time Frame: baseline, 2 weeks
|
The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
|
baseline, 2 weeks
|
Change from week 2 in the isotopic ratio of iron in blood at week 4
Time Frame: 2 weeks, 4 weeks
|
The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
|
2 weeks, 4 weeks
|
Change from week 4 in the isotopic ratio of iron in blood at week 6
Time Frame: 4 weeks, 6 weeks
|
The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
|
4 weeks, 6 weeks
|
Change from week 6 in the isotopic ratio of iron in blood at week 8
Time Frame: 6 weeks, 8 weeks
|
The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
|
6 weeks, 8 weeks
|
Change from week 8 in the isotopic ratio of iron in blood at week 10
Time Frame: 8 weeks, 10 weeks
|
The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
|
8 weeks, 10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Haemoglobin
Time Frame: 2, 4,6,8 and 10 weeks
|
Haemoglobin of each timepoint
|
2, 4,6,8 and 10 weeks
|
Plasma Ferritin
Time Frame: 2, 4, 6, 8 and 10 weeks
|
Plasma Ferritin of each timepoint
|
2, 4, 6, 8 and 10 weeks
|
Inflammation Marker
Time Frame: 2, 4, 6, 8 and 10 weeks
|
Plasma Ferririn of each timepoint
|
2, 4, 6, 8 and 10 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Iron_RiceSolubilizing
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron-deficiency
-
Pennington Biomedical Research CenterRecruitingIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNot yet recruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Swiss Federal Institute of TechnologyUnited States Agency for International Development (USAID); Quadram Institute... and other collaboratorsCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)Peru
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
Iowa State UniversityCompletedIron-deficiency | Bioavailability | Anemia, Iron Deficiency | Absorption; Iron | Serum IronUnited States
-
Société des Produits Nestlé (SPN)CompletedIron-deficiency | Anemia | Iron Deficiency AnemiaPhilippines
-
Swiss Federal Institute of TechnologyUniversity of MalawiCompletedIron-deficiency | Iron Deficiency AnemiaMalawi, Switzerland
-
Johann Wolfgang Goethe University HospitalLudwig-Maximilians - University of MunichCompletedNon-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IXIron-deficiency | Anemia | Iron Deficiency AnemiaGermany
-
Kansas State UniversityUnited States Department of Agriculture Foreign Agricultural Service; American...CompletedIron-deficiency | Iron Deficiency AnemiaUnited States
Clinical Trials on Reference meal 1
-
Unilever R&DLeatherhead Food ResearchCompleted
-
Lund UniversityCompletedMetabolic SyndromeSweden
-
University of ChesterCompletedAnemia, Iron-DeficiencyUnited Kingdom
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
Lund UniversityCompletedObesity | Metabolic SyndromeSweden
-
University of CopenhagenNordea-fondenCompletedGlucose Intolerance | Insulin SensitivityDenmark
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
Lund UniversityCompleted
-
University of NottinghamUnilever R&DCompleted
-
Glycaemic Index Testing, Inc.Sydney University Glycaemic Index Research Services; ILSI EuropeCompletedHealthyUnited Kingdom, Australia, Canada, France, United States, China, Denmark, Finland, Germany, Italy, Malaysia, Netherlands, New Zealand, Philippines, South Africa, Sweden, Trinidad and Tobago